Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Yonago Acta Medica|March 31, 2018
Resolvin E1 Inhibits Osteoclastogenesis and Bone Resorption by Suppressing IL-17-induced RANKL Expression in Osteoblasts and RANKL-induced Osteoclast DifferentiationYoshihiro Funaki, Yasuyuki Hasegawa, Ryota Okazaki, et al.
Yonago Acta Medica|March 24, 2017
DNA-PK Inhibition by NU7441 Enhances Chemosensitivity to Topoisomerase Inhibitor in Non-Small Cell Lung Carcinoma Cells by Blocking DNA Damage RepairMasaaki Yanai, Haruhiko Makino, Bingqiong Ping, et al.
International Archives of Allergy and Immunology|October 17, 2024
The Efficacy and Safety of Stepwise Oral Food Challenge in Children with Cow's Milk AllergyMika Ogata, Jun Kido, Suguru Watanabe, et al.
International Journal of Clinical Oncology|August 22, 2025
Speckled antinuclear antibody pattern as a potential predictor for immune-related adverse events in cancer patientsHiroki Kohno, Masaaki Yanai, Miyu Nishigami, et al.
Molecular and Clinical Oncology|December 30, 2017
Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastasesHiroki Izumi, Tadashi Igishi, Akira Yamasaki, et al.
Internal Medicine (Tokyo, Japan)|February 9, 2025
Pseudo-hyperprogression of Malignant Pleural Mesothelioma Treated with Nivolumab: A Case ReportMasaaki Yanai, Tomohiro Sakamoto, Takafumi Nonaka, et al.
Respirology Case Reports|June 19, 2026
Curette-Assisted Removal of a Bronchial Screw Foreign Body Refractory to Forceps GraspingGenki Inui, Kohei Yamane, Masaki Nakamoto, et al.
Internal Medicine (Tokyo, Japan)|February 2, 2025
Successful Switch to Afatinib and Osimertinib Rechallenge with Corticosteroids after Osimertinib-induced Interstitial Lung Disease: A Case Report and Literature ReviewMasaaki Yanai, Tomohiro Sakamoto, Naoki Uetani, et al.
Yonago Acta Medica|March 24, 2017
γ-Tocotrienol Inhibits TGF-β1-Induced Contractile Phenotype Expression of Human Airway Smooth Muscle CellsTakehito Fukushima, Akira Yamasaki, Tomoya Harada, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancerHiroki Izumi, Akira Yamasaki, Kenichi Takeda, et al.
Pageof 3